Merck & Co. received a second request from the U.S. Food and Drug Administration for more information on the company's application to sell its Gardasil cervical cancer vaccine to women age 27 to 45.
Copyright PHILY - Philly.com
Merck & Co. received a second request from the U.S. Food and Drug Administration for more information on the company's application to sell its Gardasil cervical cancer vaccine to women age 27 to 45.